Lung Cancer - Non-Small Cell News
Early Palliative Care Linked with Longer Lung Cancer Survival (September 1, 2010)Palliative care is care that is focused on symptom management, psychosocial issues, decision-making, and quality of life. Among patients with newly diagnosed, metastatic, non-small cell lung cancer, the addition of early palliative care to standard cancer... Continue Reading
Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (August 30, 2010)Among postmenopausal women, hormone therapy with estrogen alone does not appear to increase the risk of getting or dying from lung cancer. These results were published in the Journal of the National Cancer Institute. As women reach menopause and beyond,... Continue Reading
Study Evaluates Safety of Avastin and Chemotherapy in Non–Squamous Non–Small Cell Lung Cancer (August 3, 2010)A large Phase IV study confirms that the safety and efficacy reported in Phase III trials of Avastin® (bevacizumab) plus standard chemotherapy for patients with advanced non-squamous non-small cell lung cancer translate into the clinical practice setting.... Continue Reading
Vitamin B6 Associated with Lower Risk of Lung Cancer (June 28, 2010)Individuals with high blood levels of vitamin B6 may be less likely to develop lung cancer compared with their counterparts with lower vitamin B6 levels, according to the results of a study published in the Journal of the American Medical Association.[1] Lung... Continue Reading
Large Study Confirms that Vandetanib Is Active in Previously Treated Non–Small Cell Lung Cancer (June 15, 2010)The combination of vandetanib plus Taxotere resulted in longer survival without cancer progression than Taxotere alone among patients with previously-treated non–small cell lung cancer (NSCLC). These findings were recently published in the journal The... Continue Reading
Selenium Does Not Prevent Second Lung Cancers in Patients with Early Non-small Cell Lung Cancer (June 8, 2010)Supplementation with selenium in patients with Stage IA and IB non-small cell lung cancer does not appear to prevent a second primary lung cancer from developing, according to the results of a Phase III study presented at the 2010 annual meeting of the... Continue Reading
Combination Chemotherapy Improves Survival in Elderly Lung Cancer Patients (June 7, 2010)Among patients age 70 or older with advanced non-small cell lung cancer (NSCLC), treatment with a combination of two chemotherapy drugs—paclitaxel and carboplatin—results in better progression-free and overall survival than treatment with single-agent... Continue Reading
Large Study Indicates No Benefit of Shark Cartilage Derivative in Lung Cancer (June 7, 2010)A randomized Phase III study indicates that the addition of AE-941, a shark cartilage derivative, to standard chemoradiotherapy does not improve survival in patients with unresectable Stage III non–small cell lung cancer (NSCLC). These findings were... Continue Reading
Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)An expert panel provided consensus recommendations for appropriate prevention, surveillance and treatment of hypertension (high blood pressure) in patients treated with vascular endothelial growth factor (VEGF) signaling pathway inhibitors. These recommendations... Continue Reading
Tarceva Maintenance Therapy Prolongs Survival in Advanced NSCLC (May 27, 2010)Maintenance therapy with the targeted agent Tarceva® (erlotinib) modestly prolongs progression-free and overall survival in patients with advanced non-small cell lung cancer compared with placebo, according to the results of a phase III study published... Continue Reading
Latest Lung Cancer - Non-Small Cell News By Stage
Recurrent Lung Cancer - Non-Small Cell
Study Evaluates Safety of Avastin and Chemotherapy in Non–Squamous Non–Small Cell Lung Cancer (August 3, 2010)
A large Phase IV study confirms that the safety and efficacy reported in Phase III trials of Avastin® (bevacizumab) plus standard chemotherapy for patients with advanced non-squamous non-small cell lung cancer translate into the clinical practice setting.... Continue Reading
Large Study Confirms that Vandetanib Is Active in Previously Treated Non–Small Cell Lung Cancer (June 15, 2010)The combination of vandetanib plus Taxotere resulted in longer survival without cancer progression than Taxotere alone among patients with previously-treated non–small cell lung cancer (NSCLC). These findings were recently published in the journal The... Continue Reading
November Is National Lung Cancer Awareness Month (November 6, 2009)As the month of November brings lung cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated lung cancer information... Continue Reading
Addition of Avastin® to Tarceva® Does Not Appear to Improve Survival in Patients with Advanced Non–Small Cell Lung Cancer (March 8, 2009)Addition of Avastin® to Tarceva® Does Not Appear to Improve Survival in Patients with Advanced Non–Small Cell Lung Cancer According to the results of a Phase III clinical trial, treatment with Avastin® (bevacizumab) plus Tarceva® (erlotinib) did... Continue Reading
Nexavar® Improves Survival in Recurrent Non–Small Cell Lung Cancer (March 8, 2009)Nexavar® Improves Survival in Recurrent Non–Small Cell Lung Cancer Patients with recurrent non–small cell lung cancer (NSCLC) who were treated with Nexavar® (sorafenib) experienced a delay in disease progression and a possible improvement in overall... Continue Reading
More Recurrent Lung Cancer - Non-Small CellScreening/Prevention Lung Cancer - Non-Small Cell
Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (August 30, 2010)
Among postmenopausal women, hormone therapy with estrogen alone does not appear to increase the risk of getting or dying from lung cancer. These results were published in the Journal of the National Cancer Institute. As women reach menopause and beyond,... Continue Reading
Vitamin B6 Associated with Lower Risk of Lung Cancer (June 28, 2010)Individuals with high blood levels of vitamin B6 may be less likely to develop lung cancer compared with their counterparts with lower vitamin B6 levels, according to the results of a study published in the Journal of the American Medical Association.[1] Lung... Continue Reading
Some Blood Pressure Drugs May Raise Cancer Risk (June 23, 2010)It appears that angiotensin-receptor blockers (ARBs), a widely used class of blood pressure drugs, may slightly increase the risk of cancer. These findings were published in the Lancet Oncology. Angiotensin-receptor blockers work by blocking angiotensin... Continue Reading
Lung Cancer Risk and Traffic-related Air Pollution (May 20, 2010)Researchers report a modest association between air pollution resulting from traffic and risk of lung cancer. These findings were recently published in the journal Cancer Epidemiology, Biomarkers & Prevention.[1] Although the relationship between... Continue Reading
High Rate of False-positive Results in Lung Cancer Screening with CT Scan (April 28, 2010)Screening for lung cancer using computed tomography (CT) scans can yield a high rate of false-positive results, according to a study published in the Annals of Internal Medicine. False-positive results are risky because they may lead to invasive follow-up... Continue Reading
More Screening/Prevention Lung Cancer - Non-Small CellStages I-IIIA Lung Cancer - Non-Small Cell
Selenium Does Not Prevent Second Lung Cancers in Patients with Early Non-small Cell Lung Cancer (June 8, 2010)
Supplementation with selenium in patients with Stage IA and IB non-small cell lung cancer does not appear to prevent a second primary lung cancer from developing, according to the results of a Phase III study presented at the 2010 annual meeting of the... Continue Reading
Stereotactic Radiation May Benefit Early Non–Small Cell Lung Cancer Patients Ineligible for Surgery (May 25, 2010)Patients with early-stage non–small cell lung cancer (NSCLC) who were medically unable to undergo surgery to remove their cancer had a 55.8% overall survival at three years following stereotactic body radiation therapy. These findings were recently... Continue Reading
Phase III Trial Evaluates Preoperative Chemotherapy for Non–Small Cell Lung Cancer (May 21, 2010)A Phase III clinical trial of preoperative chemotherapy for non–small cell lung cancer did not provide definitive evidence of a benefit. The results of this prematurely closed study were recently published in the Journal of Clinical Oncology.[1] Lung... Continue Reading
Most Survivors of Lung and Colorectal Cancer Keep Their Jobs (April 14, 2010)Among people diagnosed with nonmetastatic lung or colorectal cancer, the majority return to work, according to a study recently published in Journal of Clinical Oncology. Those who do leave the workforce tend to have worse prognoses and lower socioeconomic... Continue Reading
Concurrent Radiochemotherapy Improves Survival in NSCLC (April 12, 2010)Concurrent chemotherapy delivered with radiation decreased locoregional progression and improved survival in locally advanced non–small cell lung cancer compared with sequential chemotherapy delivered before and/or after radiation. The results of... Continue Reading
More Stages I-IIIA Lung Cancer - Non-Small CellStages IIIB-IV Lung Cancer - Non-Small Cell
Early Palliative Care Linked with Longer Lung Cancer Survival (September 1, 2010)
Palliative care is care that is focused on symptom management, psychosocial issues, decision-making, and quality of life. Among patients with newly diagnosed, metastatic, non-small cell lung cancer, the addition of early palliative care to standard cancer... Continue Reading
Study Evaluates Safety of Avastin and Chemotherapy in Non–Squamous Non–Small Cell Lung Cancer (August 3, 2010)A large Phase IV study confirms that the safety and efficacy reported in Phase III trials of Avastin® (bevacizumab) plus standard chemotherapy for patients with advanced non-squamous non-small cell lung cancer translate into the clinical practice setting.... Continue Reading
Large Study Confirms that Vandetanib Is Active in Previously Treated Non–Small Cell Lung Cancer (June 15, 2010)The combination of vandetanib plus Taxotere resulted in longer survival without cancer progression than Taxotere alone among patients with previously-treated non–small cell lung cancer (NSCLC). These findings were recently published in the journal The... Continue Reading
Combination Chemotherapy Improves Survival in Elderly Lung Cancer Patients (June 7, 2010)Among patients age 70 or older with advanced non-small cell lung cancer (NSCLC), treatment with a combination of two chemotherapy drugs—paclitaxel and carboplatin—results in better progression-free and overall survival than treatment with single-agent... Continue Reading
Large Study Indicates No Benefit of Shark Cartilage Derivative in Lung Cancer (June 7, 2010)A randomized Phase III study indicates that the addition of AE-941, a shark cartilage derivative, to standard chemoradiotherapy does not improve survival in patients with unresectable Stage III non–small cell lung cancer (NSCLC). These findings were... Continue Reading
More Stages IIIB-IV Lung Cancer - Non-Small Cell